FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385683751> ?p ?o ?g. }

• W4385683751 abstract "Pseudomonas aeruginosa is a common bacterium in nosocomial infection. The biofilm-forming ability and antimicrobial resistance make P. aeruginosa biofilm infection refractory to patients requiring hospitalization, especially patients in the intensive care unit. Therefore, many alternative compounds have been developed. A newly synthesized peptide, RP557, derived from human cathelicidin LL-37, was evaluated for its antimicrobial and antibiofilm effect toward carbapenem-resistant P. aeruginosa (CRPA). The results showed that regardless of the resistance to carbapenems, the minimal inhibition concentrations of RP557 and LL-37 against P. aeruginosa were 32 µg/mL and 256 µg/mL, respectively. Both RP557 and LL-37 significantly reduced the P. aeruginosa biofilm mass at subMICs, while subMICs of carbapenems induced biofilm formation. RP557 could also remove approximately 50% of the mature biofilm at a concentration of 64 µg/mL, while 256 µg/mL LL-37 was needed to remove it. A quarter MIC of RP557 and LL-37 was used together with carbapenems (ertapenem, imipenem, and meropenem). The results show that both RP-557 and LL-37 might increase the susceptibility to CRPA by 4-16 times. Significant gene expression level changes were observed in RP557- or LL-37-treated CRPA. Confocal images showed that biofilm structures and biofilm cell viability were significantly reduced in the LL-37- or RP557-treated groups. Therefore, RP557 and its structural origin, LL-37, could be potential treatments for carbapenem-resistant P. aeruginosa infection, especially for chronic biofilm infection. IMPORTANCE Pseudomonas aeruginosa is one of the major pathogens of nosocomial infection. Combined its biofilm-forming ability with carbapenem-resistance, it is hard to handle P. aeruginosa infection, especially for patients requiring hospitalization. Antimicrobial peptide is a type of potential compound for bacterial infection treatment. Among these, RP557 was found effective in inhibiting biofilm previously. By assessing its effect on both carbapenem-resistant P. aeruginosa planktonic cells and biofilm, our results offered a potential treatment for carbapenem-resistant P. aeruginosa infection. It could be helpful to treat severe nosocomial infection related to carbapenem-resistant bacteria and increase the patients' survival rate." @default.
• W4385683751 created "2023-08-10" @default.
• W4385683751 creator A5028243784 @default.
• W4385683751 creator A5044920435 @default.
• W4385683751 creator A5045076650 @default.
• W4385683751 creator A5060839131 @default.
• W4385683751 creator A5079682131 @default.
• W4385683751 creator A5082406125 @default.
• W4385683751 date "2023-08-09" @default.
• W4385683751 modified "2023-10-16" @default.
• W4385683751 title "Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant <i>Pseudomonas aeruginosa</i>" @default.
• W4385683751 cites W1939060006 @default.
• W4385683751 cites W1964113525 @default.
• W4385683751 cites W1966552407 @default.
• W4385683751 cites W1967069761 @default.
• W4385683751 cites W1974157620 @default.
• W4385683751 cites W2015021843 @default.
• W4385683751 cites W2018989138 @default.
• W4385683751 cites W2020154280 @default.
• W4385683751 cites W2028733093 @default.
• W4385683751 cites W2049774740 @default.
• W4385683751 cites W2055613435 @default.
• W4385683751 cites W2055767311 @default.
• W4385683751 cites W2068375514 @default.
• W4385683751 cites W2093730523 @default.
• W4385683751 cites W2106859951 @default.
• W4385683751 cites W2111416348 @default.
• W4385683751 cites W2121417680 @default.
• W4385683751 cites W2131727615 @default.
• W4385683751 cites W2135822024 @default.
• W4385683751 cites W2143256071 @default.
• W4385683751 cites W2160721910 @default.
• W4385683751 cites W2165850276 @default.
• W4385683751 cites W2553758814 @default.
• W4385683751 cites W2557546772 @default.
• W4385683751 cites W2604646349 @default.
• W4385683751 cites W2790157690 @default.
• W4385683751 cites W2810726186 @default.
• W4385683751 cites W2854833382 @default.
• W4385683751 cites W2903381708 @default.
• W4385683751 cites W2904089183 @default.
• W4385683751 cites W2939347585 @default.
• W4385683751 cites W2944869268 @default.
• W4385683751 cites W2956896121 @default.
• W4385683751 cites W2991573081 @default.
• W4385683751 cites W2996661070 @default.
• W4385683751 cites W3000219671 @default.
• W4385683751 cites W3164122911 @default.
• W4385683751 cites W3184022283 @default.
• W4385683751 cites W3210197474 @default.
• W4385683751 cites W3211805452 @default.
• W4385683751 cites W3217538291 @default.
• W4385683751 cites W4224213336 @default.
• W4385683751 doi "https://doi.org/10.1128/spectrum.00430-23" @default.
• W4385683751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37555659" @default.
• W4385683751 hasPublicationYear "2023" @default.
• W4385683751 type Work @default.
• W4385683751 citedByCount "0" @default.
• W4385683751 crossrefType "journal-article" @default.
• W4385683751 hasAuthorship W4385683751A5028243784 @default.
• W4385683751 hasAuthorship W4385683751A5044920435 @default.
• W4385683751 hasAuthorship W4385683751A5045076650 @default.
• W4385683751 hasAuthorship W4385683751A5060839131 @default.
• W4385683751 hasAuthorship W4385683751A5079682131 @default.
• W4385683751 hasAuthorship W4385683751A5082406125 @default.
• W4385683751 hasBestOaLocation W43856837511 @default.
• W4385683751 hasConcept C185592680 @default.
• W4385683751 hasConcept C2776685102 @default.
• W4385683751 hasConcept C2777637488 @default.
• W4385683751 hasConcept C2778368673 @default.
• W4385683751 hasConcept C2779375183 @default.
• W4385683751 hasConcept C2779631663 @default.
• W4385683751 hasConcept C4937899 @default.
• W4385683751 hasConcept C501593827 @default.
• W4385683751 hasConcept C523546767 @default.
• W4385683751 hasConcept C54355233 @default.
• W4385683751 hasConcept C58123911 @default.
• W4385683751 hasConcept C86803240 @default.
• W4385683751 hasConcept C89423630 @default.
• W4385683751 hasConcept C94665300 @default.
• W4385683751 hasConceptScore W4385683751C185592680 @default.
• W4385683751 hasConceptScore W4385683751C2776685102 @default.
• W4385683751 hasConceptScore W4385683751C2777637488 @default.
• W4385683751 hasConceptScore W4385683751C2778368673 @default.
• W4385683751 hasConceptScore W4385683751C2779375183 @default.
• W4385683751 hasConceptScore W4385683751C2779631663 @default.
• W4385683751 hasConceptScore W4385683751C4937899 @default.
• W4385683751 hasConceptScore W4385683751C501593827 @default.
• W4385683751 hasConceptScore W4385683751C523546767 @default.
• W4385683751 hasConceptScore W4385683751C54355233 @default.
• W4385683751 hasConceptScore W4385683751C58123911 @default.
• W4385683751 hasConceptScore W4385683751C86803240 @default.
• W4385683751 hasConceptScore W4385683751C89423630 @default.
• W4385683751 hasConceptScore W4385683751C94665300 @default.
• W4385683751 hasFunder F4320322120 @default.
• W4385683751 hasLocation W43856837511 @default.
• W4385683751 hasLocation W43856837512 @default.
• W4385683751 hasOpenAccess W4385683751 @default.
• W4385683751 hasPrimaryLocation W43856837511 @default.
• W4385683751 hasRelatedWork W1970948691 @default.

• next